Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients

Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies

(2016) Amélie Marsot et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature

(2016) Jennifer Sherwin et al.   CLINICAL THERAPEUTICS

Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review

(2016) Adam S. Himebauch et al.   Expert Opinion on Drug Metabolism & Toxicology

Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case–control study

(2016) E. Gélisse et al.   INTENSIVE CARE MEDICINE

Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment

(2016) Ann-Kathrin Strunk et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation

(2016) Chien-Chih Wu et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Azithromycin Pharmacokinetics in Adults With Acute Respiratory Distress Syndrome Undergoing Treatment With Extracorporeal-Membrane Oxygenation

(2015) R. Brigg Turner et al.   ANNALS OF PHARMACOTHERAPY

Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation

(2015) Kevin M. Watt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case–control study

(2015) Katia Donadello et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation

(2015) So Jin Park et al.   PLoS One

Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation

(2015) C. Welsch et al.   Transplant Infectious Disease

Insufficient Serum Levels of Antituberculosis Agents During Venovenous Extracorporeal Membrane Oxygenation Therapy for Acute Respiratory Distress Syndrome in a Patient with Miliary Tuberculosis

(2014) Hyung-Sook Kim et al.   ASAIO JOURNAL

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

Pharmacokinetics of Continuous-Infusion Meropenem in a Pediatric Patient Receiving Extracorporeal Life Support

(2014) Jeffrey J. Cies et al.   PHARMACOTHERAPY

Extracorporeal Life Support Organization Registry Report 2012

(2013) Matthew L. Paden et al.   ASAIO JOURNAL

Pharmacokinetics of linezolid during extracorporeal membrane oxygenation

(2013) Francesco G. De Rosa et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation

(2013) Kiran Shekar et al.   BMC Anesthesiology

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy

(2012) Darren M. Roberts et al.   CRITICAL CARE MEDICINE

Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?

(2012) K. Shekar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

(2012) Kiran Shekar et al.   JOURNAL OF CRITICAL CARE

Renal function and survival in 200 patients undergoing ECMO therapy

(2012) Jan T. Kielstein et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane Oxygenation

(2012) Rachel F. Eyler et al.   PHARMACOTHERAPY

Impact of Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemodiafiltration on the Pharmacokinetics of Oseltamivir Carboxylate in Critically Ill Patients With Pandemic (H1N1) Influenza

(2012) Florian Lemaitre et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets

(2011) Kashyap Patel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea

(2011) K. Lee et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

A Review of the Fundamental Principles and Evidence Base in the Use of Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Adult Patients

(2011) Steve Allen et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

(2011) Eva Fernandez et al.   Pharmaceutics

Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk

(2010) Gregory A. Eschenauer et al.   INTENSIVE CARE MEDICINE

Determinants of drug absorption in different ECMO circuits

(2010) E. D. Wildschut et al.   INTENSIVE CARE MEDICINE

Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults*

(2010) Matthew J. Bizzarro et al.   Pediatric Critical Care Medicine

Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support

(2010) Enno D. Wildschut et al.   PLoS One

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia

(2009) I. Martin-Loeches et al.   INTENSIVE CARE MEDICINE

Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome

(2009)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation

(2009) I. Spriet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial

(2009) Giles J Peek et al.   LANCET

Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009

(2009) Seema Jain et al.   NEW ENGLAND JOURNAL OF MEDICINE